Company Overview of Speedel Pharma AG
Speedel Pharma AG was acquired by Novartis AG. Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. The company was founded in 1998 and is based in Basel, Switzerland.
Founded in 1998
41 61 206 40 00
41 61 206 40 01
Key Executives for Speedel Pharma AG
Speedel Pharma AG does not have any Key Executives recorded.
Similar Private Companies By Industry
|Acino International AG||Europe|
|AL-S Pharma AG||Europe|
|Albea Pharmaceuticals AG||Europe|
|Alpen Pharma AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Speedel Pharma AG, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.